Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0344329 (
collapse
)
28,634
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Four members of collapsin response mediator proteins (CRMPs) are thought to be involved in the semaphorin-induced growth cone
collapse
during neural development. Here we report the identification of a novel CRMP3-associated protein, designated
CRAM
for CRMP3-associated molecule, that belongs to the unc-33 gene family. The deduced amino acid sequence reveals that the
CRAM
gene encodes a protein of 563 amino acids, shows 57% identity with dihydropyrimidinase, and shows 50-51% identity with CRMPs.
CRAM
appears to form a large complex composed of CRMP3 and other unidentified proteins in vivo. Indeed,
CRAM
physically associates with CRMP3 when co-expressed in COS-7 cells. The expression of
CRAM
is brain-specific, is high in fetal and neonatal rat brain, and decreases to very low levels in adult brain. Moreover,
CRAM
expression is up-regulated during neuronal differentiation of embryonal carcinoma P19 and PC12 cells. Finally, immunoprecipitation analysis of rat brain extracts shows that
CRAM
is co-immunoprecipitated with proteins that contain protein-tyrosine kinase activity. Taken together, our results suggest that
CRAM
, which interacts with CRMP3 and protein-tyrosine kinase(s), is a new member of an emerging family of molecules that potentially mediate signals involved in the guidance and outgrowth of axons.
...
PMID:Identification of CRAM, a novel unc-33 gene family protein that associates with CRMP3 and protein-tyrosine kinase(s) in the developing rat brain. 1085 Dec 47
Collapsin response mediator proteins (CRMPs)/TOAD64/Ulips/DRPs and
CRAM
have emerged as strong candidates for a role in semaphorin signaling. In this study we identified Fes/Fps (Fes) tyrosine kinase in the CRMP-
CRAM
complex and investigated whether Fes was involved in semaphorin3A (Sema3A) signaling. In COS-7 cells, the interaction between Fes and plexinA1 (PlexA1) and the tyrosine phosphorylation of PlexA1 by Fes were observed; however, these events were significantly attenuated by co-expression of neuropilin-1 (NP-1). Even with NP-1 co-expression, Sema3A was able to enhance the association of Fes with PlexA1 and Fes-mediated tyrosine phosphorylation of PlexA1,
CRAM
and CRMP2. Co-expression of Fes with PlexA1 exhibited COS-7 cell contraction activity, indicating that Fes can convert inactive PlexA1 to its active form, whereas combination of Fes/NP-1/PlexA1 or Fes kinase-negative mutants/PlexA1 did not alter cell morphology. Finally, Sema3A-induced growth cone
collapse
of dorsal root ganglion neurons was suppressed by expression of Fes kinase-negative mutants. Taken together, our findings suggest that Fes links Sema3A signals to CRMP-
CRAM
, and that NP-1 negatively regulates PlexA1 activation by Fes in resting condition.
...
PMID:Involvement of Fes/Fps tyrosine kinase in semaphorin3A signaling. 1209 29